Page 13 - Ancer Prostate News Today

Why are US hospitals -- which may pay as little as $260 for the drug -- charging so much more to administer it?

A shorter course of hypofractionated radiotherapy should be considered for patients with high-risk prostate cancer, say trialists, who report that efficacy and toxicity are similar to longer standard regimens.

177Lu-PSMA SPECT at cycle three (week 12) of six cycles of PSMA-targeted treatment predicted progression-free survival for men with end-stage metastatic castration-resistant prostate cancer.

High PSMA (mean SUV of 10 or greater) predicts good response to 177Lu-PSMA-617 and promises to help clinicians optimize the best patients to treat with the radioligand therapy, researchers say.

Although the findings focus on deaths before vaccines became available, the data can help researchers better understand some of the burden COVID-19 had on patients with cancer.

A dental school dean with a history of publishing cancer research papers is up to five retractions.

Prostate cancer risk stratification based on family history plus inherited polygenic risk can better identify men at highest risk of dying from prostate cancer at an early age, new data suggest.

Patients who live near state borders dont have the same access to telehealth that other residents do in some states; people in rural areas are also affected, according to new research.

"Its very challenging in a rural or small community. I miss the opportunity to elaborate on a case."

Androgen deprivation therapy (ADT) given for 24 months in the postoperative setting, combined with radiotherapy, was superior to 6 months of administration for improving metastasis-free survival.